ID

15075

Descripción

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470; ODM derived from: https://clinicaltrials.gov/show/NCT02302443

Link

https://clinicaltrials.gov/show/NCT02302443

Palabras clave

Versiones (1)
  1. 14/5/16 14/5/16 -
Subido en

14 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus NCT02302443

Inglés

Eligibility Diabetes Mellitus NCT02302443

1 formularios  
Criteria
Descripción

Criteria

t2dm more than 12 monthm
Descripción

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
age ≥18 and ≤70 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
body mass index between 18.0 and 35.0 kg/m2 inclusive.
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
Descripción

Healthy | Medical History | Physical Examination | Biochemical finding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3898900
UMLS CUI [2]
C0262926
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0428132
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
Descripción

Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086287
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0041275
UMLS CUI [6]
C0020699
UMLS CUI [7]
C2243030
UMLS CUI [8]
C0278321
UMLS CUI [9]
C0232970
UMLS CUI [10]
C0086582
UMLS CUI [11]
C0024559
UMLS CUI [12]
C0036899
UMLS CUI [13]
C3831118
UMLS CUI [14]
C0700589
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
Descripción

Informed Consent | Research Activities

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0242481
inclusion criteria for t2dm:
Descripción

Inclusion | Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1512693
UMLS CUI [2]
C0011860
t1dm more than 12 monthm
Descripción

Diabetes Mellitus, Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
age ≥18 and ≤70 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
body mass index between 18.0 and 30.0 kg/m2 inclusive.
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
Descripción

Healthy | Medical History | Physical Examination | Biochemical finding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3898900
UMLS CUI [2]
C0262926
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0428132
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
Descripción

Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086287
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0041275
UMLS CUI [6]
C0020699
UMLS CUI [7]
C2243030
UMLS CUI [8]
C0278321
UMLS CUI [9]
C0232970
UMLS CUI [10]
C0086582
UMLS CUI [11]
C0024559
UMLS CUI [12]
C0036899
UMLS CUI [13]
C3831118
UMLS CUI [14]
C0700589
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
Descripción

informed consent | Research Activities

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0242481
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
a subject who has proliferative retinopathy or maculopathy, severe gastroparesis, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
Descripción

Proliferative retinopathy | Disorder of macula of retina Proliferative | Gastroparesis Severe | Neuropathy Severe | Autonomic neuropathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0339467
UMLS CUI [2,1]
C0730362
UMLS CUI [2,2]
C0334094
UMLS CUI [3,1]
C0152020
UMLS CUI [3,2]
C0205082
UMLS CUI [4,1]
C0442874
UMLS CUI [4,2]
C0205082
UMLS CUI [5]
C0259749
recurrent major hypoglycemia or hypoglycemic unawareness or recent ketoacidosis
Descripción

Hypoglycemia Major Recurrent | Hypoglycemia unawareness | Ketoacidosis Recent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205164
UMLS CUI [1,3]
C2945760
UMLS CUI [2]
C0342317
UMLS CUI [3,1]
C0220982
UMLS CUI [3,2]
C0332185
pregnant or lactating women
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
participation in an investigational study within 30 days prior to dosing
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
clinically significant abnormal ecg at screening, as judged by the investigator
Descripción

Electrocardiogram abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0522055
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus NCT02302443

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Diabetes Mellitus, Non-Insulin-Dependent
Item
t2dm more than 12 monthm
boolean
C0011860 (UMLS CUI [1])
Age
Item
age ≥18 and ≤70 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index between 18.0 and 35.0 kg/m2 inclusive.
boolean
C1305855 (UMLS CUI [1])
Healthy | Medical History | Physical Examination | Biochemical finding
Item
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
boolean
C3898900 (UMLS CUI [1])
C0262926 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C0428132 (UMLS CUI [4])
Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods
Item
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
boolean
C0086287 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0041275 (UMLS CUI [5])
C0020699 (UMLS CUI [6])
C2243030 (UMLS CUI [7])
C0278321 (UMLS CUI [8])
C0232970 (UMLS CUI [9])
C0086582 (UMLS CUI [10])
C0024559 (UMLS CUI [11])
C0036899 (UMLS CUI [12])
C3831118 (UMLS CUI [13])
C0700589 (UMLS CUI [14])
Informed Consent | Research Activities
Item
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
boolean
C0021430 (UMLS CUI [1])
C0242481 (UMLS CUI [2])
Inclusion | Diabetes Mellitus, Non-Insulin-Dependent
Item
inclusion criteria for t2dm:
boolean
C1512693 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent
Item
t1dm more than 12 monthm
boolean
C0011854 (UMLS CUI [1])
Age
Item
age ≥18 and ≤70 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index between 18.0 and 30.0 kg/m2 inclusive.
boolean
C1305855 (UMLS CUI [1])
Healthy | Medical History | Physical Examination | Biochemical finding
Item
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
boolean
C3898900 (UMLS CUI [1])
C0262926 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C0428132 (UMLS CUI [4])
Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods
Item
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
boolean
C0086287 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0041275 (UMLS CUI [5])
C0020699 (UMLS CUI [6])
C2243030 (UMLS CUI [7])
C0278321 (UMLS CUI [8])
C0232970 (UMLS CUI [9])
C0086582 (UMLS CUI [10])
C0024559 (UMLS CUI [11])
C0036899 (UMLS CUI [12])
C3831118 (UMLS CUI [13])
C0700589 (UMLS CUI [14])
informed consent | Research Activities
Item
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
boolean
C0021430 (UMLS CUI [1])
C0242481 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Proliferative retinopathy | Disorder of macula of retina Proliferative | Gastroparesis Severe | Neuropathy Severe | Autonomic neuropathy
Item
a subject who has proliferative retinopathy or maculopathy, severe gastroparesis, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
boolean
C0339467 (UMLS CUI [1])
C0730362 (UMLS CUI [2,1])
C0334094 (UMLS CUI [2,2])
C0152020 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0442874 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0259749 (UMLS CUI [5])
Hypoglycemia Major Recurrent | Hypoglycemia unawareness | Ketoacidosis Recent
Item
recurrent major hypoglycemia or hypoglycemic unawareness or recent ketoacidosis
boolean
C0020615 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C2945760 (UMLS CUI [1,3])
C0342317 (UMLS CUI [2])
C0220982 (UMLS CUI [3,1])
C0332185 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in an investigational study within 30 days prior to dosing
boolean
C2348568 (UMLS CUI [1])
Electrocardiogram abnormal
Item
clinically significant abnormal ecg at screening, as judged by the investigator
boolean
C0522055 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial